Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation.

Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation.

Item
http://www.wikidata.org/entity/Q33414472
γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusNew approaches to radiation protectionThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsMedical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.Radiation countermeasure agents: an update (2011-2014)Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects.Animal models for acute radiation syndrome drug discovery.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in larRadioprotective Agents: Strategies and Translational Advances.Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.Nonhuman primates as models for the discovery and development of radiation countermeasures.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Biologics as countermeasures for acute radiation syndrome: where are we now?Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure.A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.
P2860

Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation.

Item
http://www.wikidata.org/entity/Q33414472
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Randomized comparison of singl ...... s exposed to lethal radiation.
@ast
Randomized comparison of singl ...... s exposed to lethal radiation.
@en
type
label
Randomized comparison of singl ...... s exposed to lethal radiation.
@ast
Randomized comparison of singl ...... s exposed to lethal radiation.
@en
prefLabel
Randomized comparison of singl ...... s exposed to lethal radiation.
@ast
Randomized comparison of singl ...... s exposed to lethal radiation.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Randomized comparison of singl ...... s exposed to lethal radiation.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932